During the past decade, Maine Medical Partners - South Portland conducted 58 clinical trials. In the 10-year time frame, 58 clinical trials started and 7 clinical trials were completed, i.e. on average, 12.1% percent of trials that started reached the finish line to date. In the past 5 years, 37 clinical trials started and 5 clinical trials were completed. i.e. 13.5% of trials that started reached the finish line.

Out of the total clinical trials conducted in "Maine Medical Partners - South Portland" #1 sponsor was "National Cancer Institute (NCI)" with 28 trials, followed by "Alliance for Clinical Trials in Oncology" with 6 trials sponsored, "ECOG-ACRIN Cancer Research Group" with 6 trials sponsored, "NRG Oncology" with 6 trials sponsored and "SWOG Cancer Research Network" with 6 trials sponsored. Other sponsors include 6 different institutions and companies that sponsored additional 13 trials in total.

In terms of collaborators to trials, out of the total clinical trials conducted in "Maine Medical Partners - South Portland" #1 collaborator was "National Cancer Institute (NCI)" with 26 trials as a collaborator, "NRG Oncology" with 5 trials as a collaborator, "Canadian Cancer Trials Group" with 4 trials as a collaborator, "Astellas Pharma Inc" with 1 trials as a collaborator and "Bayer" with 1 trials as a collaborator. Other collaborators include 5 different institutions and companies that were collaborators in the rest 15 trials.

According to Clinical.Site data, the most researched conditions in "Maine Medical Partners - South Portland" are "Stage IV Lung Cancer AJCC v8" (7 trials), "Recurrent Lung Non-Small Cell Carcinoma" (5 trials), "Stage IVA Lung Cancer AJCC v8" (4 trials), "Stage IVB Lung Cancer AJCC v8" (4 trials) and "Cystic Fibrosis" (3 trials). Many other conditions were trialed in "Maine Medical Partners - South Portland" in a lesser frequency.

Most popular intervention types in "Maine Medical Partners - South Portland" are "Drug" (51 trials), "Other" (37 trials), "Procedure" (26 trials), "Biological" (24 trials) and "Radiation" (18 trials). Other intervention types were less common.

The name of intervention was led by "Quality-of-Life Assessment" (22 trials), "Computed Tomography" (17 trials), "Questionnaire Administration" (17 trials), "Biospecimen Collection" (15 trials) and "Nivolumab" (12 trials). Other intervention names were less common.

The vast majority of trials in "Maine Medical Partners - South Portland" are 54 trials for "All" genders, 6 trials for "Male" genders and 3 trials for "Female" genders.

Currently, there are NaN active trials in "Maine Medical Partners - South Portland". undefined are not yet recruiting, 30 are recruiting, 23 are Active, not recruiting, and undefined are Enrolling by invitation. In total, there were 6 completed trials in Maine Medical Partners - South Portland, 3 suspended trials, and 1 terminated clinical trials to date.

Out of the total trials that were conducted in Maine Medical Partners - South Portland, 1 "Phase 1" clinical trials were conducted, 24 "Phase 2" clinical trials and 42 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 0 trials, and there were also 3 trials that are defined as “Not Applicable".

Maine Medical Partners - South Portland has several departments that took part in Clinical trials: "Maine Cardiology Associates" - 6 trials, "Maine Medical Partners Pediatric Specialty Care" - 6 trials, "Maine Medical Center Pediatrics-Site Number:840064" - 3 trials, "Maine Nephrology Associates" - 2 trials